📇 Rhumatologue · CLICHY CEDEX · (92) · Mixte
Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
4 raisons identifiées
Plateau technique de référence
Assistance publique – Hôpitaux de Paris (APHP) — équipements et expertise pointus pour les cas complexes
Praticien-chercheur
7 articles scientifiques publiés — formation continue solide
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
136 rhumatos / 100 000 hab. — département bien doté
7 publications sur 5 ans
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
7
7 articles ont été cités au moins 7fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
543
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
26
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
6
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Affiliations FR : Hôpital Beaujon · Assistance Publique – Hôpitaux de Paris · Assistance Publique – Hôpitaux de Paris
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Identification of protease-sensitive but not misfolding PNLIP variants in familial and hereditary pancreatitis
2023ArticlePancreatology
The PRSS3P2 and TRY7 deletion copy number variant modifies risk for chronic pancreatitis
2022ArticlePancreatology
Endoscopic ultrasound‐guided drainage using lumen‐apposing metal stent of malignant afferent limb syndrome in patients with previous Whipple surgery: Multicenter study (with video)
2022ArticleDigestive Endoscopy
Drastic decrease of urgent endoscopies outside regular working hours during the Covid-19 pandemic in the paris area
2020ArticleClinics and Research in Hepatology and Gastroenterology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
GHU APHP NUP SITE BEAUJON
100 BD DU GENERAL LECLERC, 92118 CLICHY CEDEX
CABINET DU DR BEnEdicte JAIS
CLINIQUE CLAUDE BERNARD 9 AVENUE LOUIS ARMAND, 95120 ERMONT
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2022
ObjectivesEndoscopic ultrasound‐guided digestive anastomosis (EUS‐A) is a new alternative under evaluation in patients presenting with afferent limb syndrome (ALS) after Whipple surgery. The aim of the present study is to analyze the safety and effectiveness of EUS‐A in ALS.MethodsThis is an observational multicenter study. All patients ≥18 years old with previous Whipple surgery presenting with ALS who underwent an EUS‐A using a lumen‐apposing metal stent (LAMS) between 2015 and 2021 were included. The primary outcome was clinical success, defined as resolution of the ALS or ALS‐related cholangitis. Furthermore, technical success, adverse event rate, and mortality were evaluated.ResultsForty‐five patients (mean age: 65.5 ± 10.2 years; 44.4% male) were included. The most common underlying disease was pancreatic cancer (68.9%). EUS‐A was performed at a median of 6 weeks after local tumor recurrence. The most common approach used was the direct/freehand technique (66.7%). Technical success was achieved in 95.6%, with no differences between large (≥15 mm) and small LAMS (97.4% vs. 100%, P = 0.664). Clinical success was retained in 91.1% of patients. A complementary treatment by dilation of the stent followed by endoscopic retrograde cholangiopancreatography through the LAMS was performed in three cases (6.7%). There were six recurrent episodes of cholangitis (14.6%) and two procedure‐related adverse events (4.4%) after a median follow‐up of 4 months. Twenty‐six patients (57.8%) died during the follow‐up due to disease progression.ConclusionEUS‐A is a safe and effective technique in the treatment of malignant ALS, achieving high clinical success with an acceptable recurrence rate.
Clinics and research in hepatology and gastroenterology · 2022
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Clinical and translational gastroenterology · 2026 · Journal Article
Marcellier G, Edery N, Pratico C, Jais B, et al.
Endoscopy international open · 2026 · Journal Article
Marcellier G, Hedjoudje A, Jais B, Maire F, et al.
Therapeutic advances in gastrointestinal endoscopy · 2021 · Journal Article
Hedjoudje A, Cheurfa C, Farha J, Jaïs B, et al.
Clinical and translational gastroenterology · 2026 · Journal Article
Marcellier G, Edery N, Pratico C, Jais B, et al.
VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2022 · Journal Article
Martin A, Rivallin P, Maire F, Lorenzo D, et al.
Clinical and translational gastroenterology · 2026 · Journal Article
Marcellier G, Edery N, Pratico C, Jais B, et al.
Therapeutic advances in gastrointestinal endoscopy · 2021 · Journal Article
Hedjoudje A, Cheurfa C, Farha J, Jaïs B, et al.
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2022 · Observational Study
Pérez-Cuadrado-Robles E, Bronswijk M, Prat F, Barthet M, et al.
Endoscopy · 2022 · Journal Article
Marcellier G, Lorenzo D, Hedjoudje A, Jais B, et al.
Clinics and research in hepatology and gastroenterology · 2022 · Journal Article
Perrod G, Perez-Cuadrado-Robles E, Coron E, Pioche M, et al.
Clinical and translational gastroenterology · 2026 · Journal Article
Marcellier G, Edery N, Pratico C, Jais B, et al.
Gastrointestinal bleeding in patients with pancreatic cancer: Causes and haemostatic treatments
BackgroundGastrointestinal bleeding is a rare but severe complication of pancreatic ductal adenocarcinoma.ObjectiveThe purpose of this study was to describe the causes and treatments of non-postoperative gastrointestinal
Safety of different electrocautery modes for endoscopic sphincterotomy: a Bayesian network meta-analysis
Background and aims:Post-endoscopic retrograde cholangiopancreatography acute pancreatitis (PAP) and post-sphincterotomy hemorrhage are known adverse events of post-endoscopic retrograde cholangiopancreatography. Various
Gastrointestinal bleeding in patients with pancreatic cancer: Causes and haemostatic treatments
BackgroundGastrointestinal bleeding is a rare but severe complication of pancreatic ductal adenocarcinoma.ObjectiveThe purpose of this study was to describe the causes and treatments of non-postoperative gastrointestinal
Safety of different electrocautery modes for endoscopic sphincterotomy: a Bayesian network meta-analysis
Background and aims:Post-endoscopic retrograde cholangiopancreatography acute pancreatitis (PAP) and post-sphincterotomy hemorrhage are known adverse events of post-endoscopic retrograde cholangiopancreatography. Various
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).